Company Filing History:
Years Active: 2008-2013
Title: Innovations of Anders Kronström
Introduction
Anders Kronström is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 4 patents to his name, his work has had a meaningful impact on medical science.
Latest Patents
Kronström's latest patents focus on a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1-benzimidazole, known as S-omeprazole. More specifically, these patents relate to a new form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The inventions also encompass processes for preparing this magnesium salt form of S-omeprazole and pharmaceutical compositions that contain it. Additionally, new intermediates used in the preparation process are also covered in his patents.
Career Highlights
Anders Kronström is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions in drug development. His contributions have been instrumental in advancing pharmaceutical research and improving patient outcomes.
Collaborations
Kronström has collaborated with several professionals in his field, including Hanna Cotton and Anders Mattson. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical products.
Conclusion
Anders Kronström's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving healthcare solutions.